Analysis Metabolite Name Measured Value Units hours treatment
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)455216raw area count72 LPS_IC
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)749568raw area count72 IL10
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)874125raw area count24 NT
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1102027raw area count72 IL4_IL13
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1185411raw area count72 LPS_IFNG
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1449120raw area count72 LPS_IFNG
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1540575raw area count72 IL6_LIF
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1636962raw area count72 NT
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)2063047raw area count72 NT
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)2280002raw area count24 LPS_IC
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)2298017raw area count24 IL4_IL13
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)2395528raw area count72 LPS_IC
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)2526965raw area count24 IL10
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)2773835raw area count24 IL6_LIF
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)3194754raw area count72 NT
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)3382598raw area count72 IL4_IL13
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)4023621raw area count72 IL10
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)4293308raw area count72 IL6_LIF
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)4493260raw area count72 LPS_IC
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)6104602raw area count24 LPS_IFNG
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)6722449raw area count24 IL10
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)7930366raw area count72 LPS_IFNG
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)8822199raw area count24 LPS_IC
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)9916418raw area count24 IL6_LIF
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)11398962raw area count72 IL10
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)11543723raw area count24 IL4_IL13
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)12794525raw area count72 IL4_IL13
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)13494013raw area count72 IL6_LIF
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)18849090raw area count24 NT
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)21739416raw area count24 LPS_IC
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)22918300raw area count24 IL4_IL13
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)23472264raw area count24 IL6_LIF
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)24687380raw area count24 LPS_IFNG
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)25379036raw area count24 LPS_IFNG
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)27195950raw area count24 NT
Reversed phase POSITIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)27528370raw area count24 IL10

Return to search page
  logo